{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T16:33:43Z","timestamp":1790354023647,"version":"4.1.0"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,11]],"date-time":"2021-03-11T00:00:00Z","timestamp":1615420800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000041","name":"American Diabetes Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000041","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"NIDDK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.bone.2021.115913","type":"journal-article","created":{"date-parts":[[2021,3,18]],"date-time":"2021-03-18T22:11:15Z","timestamp":1616105475000},"page":"115913","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":54,"special_numbering":"C","title":["PPARG in osteocytes controls sclerostin expression, bone mass, marrow adiposity and mediates TZD-induced bone loss"],"prefix":"10.1016","volume":"147","author":[{"given":"Sudipta","family":"Baroi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr J.","family":"Czernik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Chougule","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick R.","family":"Griffin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beata","family":"Lecka-Czernik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.bone.2021.115913_bb0005","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/s41574-019-0246-y","article-title":"The role of osteoblasts in energy homeostasis","volume":"15","author":"Dirckx","year":"2019","journal-title":"Nat Rev Endocrinol"},{"issue":"7","key":"10.1016\/j.bone.2021.115913_bb0010","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1007\/s00125-017-4283-6","article-title":"Diabetes, bone and glucose-lowering agents: clinical outcomes","volume":"60","author":"Schwartz","year":"2017","journal-title":"Diabetologia"},{"issue":"7","key":"10.1016\/j.bone.2021.115913_bb0015","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1007\/s00125-017-4269-4","article-title":"Diabetes, bone and glucose-lowering agents: basic biology","volume":"60","author":"Lecka-Czernik","year":"2017","journal-title":"Diabetologia"},{"issue":"5","key":"10.1016\/j.bone.2021.115913_bb0020","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/nm.3159","article-title":"PPAR\u03b3 signaling and metabolism: the good, the bad and the future","volume":"19","author":"Ahmadian","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.bone.2021.115913_bb0025","doi-asserted-by":"crossref","first-page":"704165","DOI":"10.1155\/2008\/704165","article-title":"PPARgamma and apoptosis in cancer","volume":"2008","author":"Elrod","year":"2008","journal-title":"PPAR Res."},{"issue":"sup1","key":"10.1016\/j.bone.2021.115913_bb0030","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1185\/030079905X36440","article-title":"PPAR\u03b3 and atherosclerosis","volume":"21","author":"Staels","year":"2005","journal-title":"Current Medical Research and Opinion"},{"issue":"3","key":"10.1016\/j.bone.2021.115913_bb0035","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/(SICI)1097-4644(19990901)74:3<357::AID-JCB5>3.0.CO;2-7","article-title":"Inhibition of Osf2\/Cbfa1 expression and terminal osteoblast differentiation by PPARgamma2","volume":"74","author":"Lecka-Czernik","year":"1999","journal-title":"J. Cell. Biochem."},{"issue":"2","key":"10.1016\/j.bone.2021.115913_bb0040","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1002\/jcb.21994","article-title":"PPARgamma2 nuclear receptor controls multiple regulatory pathways of osteoblast differentiation from marrow mesenchymal stem cells","volume":"106","author":"Shockley","year":"2009","journal-title":"J. Cell. Biochem."},{"issue":"12","key":"10.1016\/j.bone.2021.115913_bb0045","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1038\/nm1672","article-title":"PPAR-\u03b3 regulates osteoclastogenesis in mice","volume":"13","author":"Wan","year":"2007","journal-title":"Nat. Med."},{"issue":"5","key":"10.1016\/j.bone.2021.115913_bb0050","doi-asserted-by":"crossref","first-page":"845","DOI":"10.2337\/dc07-2270","article-title":"Rosiglitazone-associated fractures in type 2 diabetes: an analysis from a diabetes outcome progression trial (ADOPT)","volume":"31","author":"Kahn","year":"2008","journal-title":"Diabetes Care"},{"issue":"11","key":"10.1016\/j.bone.2021.115913_bb0055","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1038\/nm.4208","article-title":"PPAR-gamma regulates pharmacological but not physiological or pathological osteoclast formation","volume":"22","author":"Zou","year":"2016","journal-title":"Nat. Med."},{"key":"10.1016\/j.bone.2021.115913_bb0060","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.ebiom.2016.06.040","article-title":"PPARG post-translational modifications regulate bone formation and bone Resorption","volume":"10","author":"Stechschulte","year":"2016","journal-title":"EBioMedicine"},{"key":"10.1016\/j.bone.2021.115913_bb0065","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.bone.2016.10.007","article-title":"Role and mechanism of action of sclerostin in bone","volume":"96","author":"Delgado-Calle","year":"2017","journal-title":"Bone"},{"issue":"15","key":"10.1016\/j.bone.2021.115913_bb0070","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1056\/NEJMoa1708322","article-title":"Romosozumab or alendronate for fracture prevention in women with osteoporosis","volume":"377","author":"Saag","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.bone.2021.115913_bb0075","first-page":"317","article-title":"Sclerostin as a potential novel biomarker for aortic valve calcification: an in-vivo and ex-vivo study","volume":"22","author":"Koos","year":"2013","journal-title":"J Heart Valve Dis"},{"key":"10.1016\/j.bone.2021.115913_bb0080","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1186\/1471-2369-14-219","article-title":"Relationship between sclerostin and cardiovascular calcification in hemodialysis patients: a cross-sectional study","volume":"14","author":"Brandenburg","year":"2013","journal-title":"BMC Nephrol."},{"issue":"5","key":"10.1016\/j.bone.2021.115913_bb0085","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1002\/jbmr.4001","article-title":"Serious adverse events with Romosozumab use in Japanese patients: need for clear formulation of contraindications worldwide","volume":"35","author":"Kawaguchi","year":"2020","journal-title":"J. Bone Miner. Res."},{"issue":"5","key":"10.1016\/j.bone.2021.115913_bb0090","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1002\/jbmr.4000","article-title":"Reply to serious adverse events with Romosozumab use in Japanese patients: need for clear formulation of contraindications worldwide","volume":"35","author":"Saag","year":"2020","journal-title":"J. Bone Miner. Res."},{"issue":"5","key":"10.1016\/j.bone.2021.115913_bb0095","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0019595","article-title":"The appearance and modulation of osteocyte marker expression during calcification of vascular smooth muscle cells","volume":"6","author":"Zhu","year":"2011","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.bone.2021.115913_bb0100","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1161\/ATVBAHA.116.308723","article-title":"Wnt signaling pathway inhibitor sclerostin inhibits angiotensin II-induced aortic aneurysm and atherosclerosis","volume":"37","author":"Krishna","year":"2017","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"6","key":"10.1016\/j.bone.2021.115913_bb0105","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1002\/jbmr.3397","article-title":"SOST\/Sclerostin improves posttraumatic osteoarthritis and inhibits MMP2\/3 expression after injury","volume":"33","author":"Chang","year":"2018","journal-title":"J. Bone Miner. Res."},{"issue":"330","key":"10.1016\/j.bone.2021.115913_bb0110","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aac4351","article-title":"Sclerostin inhibition promotes TNF-dependent inflammatory joint destruction","volume":"8","author":"Wehmeyer","year":"2016","journal-title":"Sci Transl Med"},{"issue":"6","key":"10.1016\/j.bone.2021.115913_bb0115","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1210\/en.2006-1587","article-title":"Rosiglitazone induces decreases in bone mass and strength that are reminiscent of aged bone","volume":"148","author":"Lazarenko","year":"2007","journal-title":"Endocrinology"},{"issue":"7","key":"10.1016\/j.bone.2021.115913_bb0120","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1002\/jbmr.141","article-title":"Guidelines for assessment of bone microstructure in rodents using micro-computed tomography","volume":"25","author":"Bouxsein","year":"2010","journal-title":"J. Bone Miner. Res."},{"issue":"5","key":"10.1016\/j.bone.2021.115913_bb0125","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1111\/j.1469-7580.2012.01483.x","article-title":"Coronary artery wall imaging in mice using osmium tetroxide and micro-computed tomography (micro-CT)","volume":"220","author":"Pai","year":"2012","journal-title":"J. Anat."},{"issue":"1","key":"10.1016\/j.bone.2021.115913_bb0130","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/jbmr.1805","article-title":"Standardized nomenclature, symbols, and units for bone histomorphometry: a 2012 update of the report of the ASBMR Histomorphometry nomenclature committee","volume":"28","author":"Dempster","year":"2013","journal-title":"J. Bone Miner. Res."},{"issue":"6","key":"10.1016\/j.bone.2021.115913_bb0135","doi-asserted-by":"crossref","first-page":"361","DOI":"10.2144\/0000113876","article-title":"Isolation and culture of primary osteocytes from the long bones of skeletally mature and aged mice","volume":"52","author":"Stern","year":"2012","journal-title":"Biotechniques"},{"issue":"12","key":"10.1016\/j.bone.2021.115913_bb0140","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.1128\/MCB.01428-09","article-title":"Osteocyte Wnt\/beta-catenin signaling is required for normal bone homeostasis","volume":"30","author":"Kramer","year":"2010","journal-title":"Mol. Cell. Biol."},{"issue":"2","key":"10.1016\/j.bone.2021.115913_bb0145","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/nprot.2006.98","article-title":"Chromatin immunoprecipitation and microarray-based analysis of protein location","volume":"1","author":"Lee","year":"2006","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.bone.2021.115913_bb0150","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.bone.2016.11.024","article-title":"Sclerostin expression and functions beyond the osteocyte","volume":"96","author":"Weivoda","year":"2017","journal-title":"Bone"},{"issue":"10","key":"10.1016\/j.bone.2021.115913_bb0155","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1002\/jbmr.3467","article-title":"Conditional deletion of Sost in MSC-derived lineages identifies specific cell-type contributions to bone mass and B-cell development","volume":"33","author":"Yee","year":"2018","journal-title":"Journal of Bone and Mineral Research: The Official Journal of the American Society for Bone and Mineral Research"},{"issue":"3","key":"10.1016\/j.bone.2021.115913_bb0160","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1002\/jbmr.1773","article-title":"Changes in bone sclerostin levels in mice after ovariectomy vary independently of changes in serum sclerostin levels","volume":"28","author":"Jastrzebski","year":"2013","journal-title":"J. Bone Miner. Res."},{"issue":"2","key":"10.1016\/j.bone.2021.115913_bb0165","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.bone.2011.08.010","article-title":"Wnt6, Wnt10a and Wnt10b inhibit adipogenesis and stimulate osteoblastogenesis through a beta-catenin-dependent mechanism","volume":"50","author":"Cawthorn","year":"2012","journal-title":"Bone"},{"issue":"11","key":"10.1016\/j.bone.2021.115913_bb0170","doi-asserted-by":"crossref","first-page":"4577","DOI":"10.1210\/en.2005-0239","article-title":"Chronic elevation of parathyroid hormone in mice reduces expression of sclerostin by osteocytes: a novel mechanism for hormonal control of osteoblastogenesis","volume":"146","author":"Bellido","year":"2005","journal-title":"Endocrinology"},{"issue":"12","key":"10.1016\/j.bone.2021.115913_bb0175","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1359\/jbmr.070804","article-title":"Control of the SOST bone enhancer by PTH using MEF2 transcription factors","volume":"22","author":"Leupin","year":"2007","journal-title":"J. Bone Miner. Res."},{"issue":"3","key":"10.1016\/j.bone.2021.115913_bb0180","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1002\/jbmr.2381","article-title":"HDAC5 controls MEF2C-driven sclerostin expression in osteocytes","volume":"30","author":"Wein","year":"2015","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2021.115913_bb0185","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.jsbmb.2015.09.005","article-title":"Analysis of SOST expression using large minigenes reveals the MEF2C binding site in the evolutionarily conserved region (ECR5) enhancer mediates forskolin, but not 1,25-dihydroxyvitamin D3 or TGFbeta1 responsiveness","volume":"164","author":"John","year":"2016","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.bone.2021.115913_bb0190","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.bone.2016.10.009","article-title":"Transcriptional control of Sost in bone","volume":"96","author":"Sebastian","year":"2017","journal-title":"Bone"},{"issue":"14","key":"10.1016\/j.bone.2021.115913_bb0195","doi-asserted-by":"crossref","first-page":"13849","DOI":"10.1074\/jbc.M306249200","article-title":"Cbfa1\/RUNX2 directs specific expression of the sclerosteosis gene (SOST)","volume":"279","author":"Sevetson","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.bone.2021.115913_bb0200","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.bbrc.2010.08.128","article-title":"Sclerostin is a direct target of osteoblast-specific transcription factor osterix","volume":"400","author":"Yang","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"2","key":"10.1016\/j.bone.2021.115913_bb0205","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.bbrc.2014.11.120","article-title":"Zinc finger protein 467 regulates Wnt signaling by modulating the expression of sclerostin in adipose derived stem cells","volume":"456","author":"You","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"4","key":"10.1016\/j.bone.2021.115913_bb0210","doi-asserted-by":"crossref","first-page":"3540","DOI":"10.1002\/jcp.26211","article-title":"TIEG and estrogen modulate SOST expression in the murine skeleton","volume":"233","author":"Subramaniam","year":"2018","journal-title":"J. Cell. Physiol."},{"issue":"3","key":"10.1016\/j.bone.2021.115913_bb0215","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1007\/s00223-016-0144-4","article-title":"Osterix and RUNX2 are transcriptional regulators of Sclerostin in human bone","volume":"99","author":"Perez-Campo","year":"2016","journal-title":"Calcif. Tissue Int."},{"issue":"4","key":"10.1016\/j.bone.2021.115913_bb0220","doi-asserted-by":"crossref","first-page":"R133","DOI":"10.1530\/REP-16-0417","article-title":"The role of sex steroids in white adipose tissue adipocyte function","volume":"153","author":"Newell-Fugate","year":"2017","journal-title":"Reproduction"},{"issue":"9","key":"10.1016\/j.bone.2021.115913_bb0225","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1007\/s00198-008-0574-6","article-title":"Effects of estrogen therapy on bone marrow adipocytes in postmenopausal osteoporotic women","volume":"19","author":"Syed","year":"2008","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bone.2021.115913_bb0230","doi-asserted-by":"crossref","first-page":"188","DOI":"10.3389\/fendo.2017.00188","article-title":"Marrow adipose tissue: skeletal location, sexual dimorphism, and response to sex steroid deficiency","volume":"8","author":"Lecka-Czernik","year":"2017","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.bone.2021.115913_bb0235","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.mce.2015.06.021","article-title":"1\u03b1,25-dihydroxyvitamin D3 stimulates human SOST gene expression and sclerostin secretion","volume":"413","author":"Wijenayaka","year":"2015","journal-title":"Mol. Cell. Endocrinol."},{"issue":"15","key":"10.1016\/j.bone.2021.115913_bb0240","doi-asserted-by":"crossref","first-page":"9141","DOI":"10.1074\/jbc.271.15.9141","article-title":"Preferential binding of MyoD-E12 versus myogenin-E12 to the murine sarcoma virus enhancer in vitro","volume":"271","author":"Czernik","year":"1996","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.bone.2021.115913_bb0245","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1002\/jcb.25432","article-title":"Sclerostin enhances adipocyte differentiation in 3T3-L1 cells","volume":"117","author":"Ukita","year":"2016","journal-title":"J. Cell. Biochem."},{"issue":"2","key":"10.1016\/j.bone.2021.115913_bb0250","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1002\/jcp.25976","article-title":"The skeletal cell-derived molecule sclerostin drives bone marrow adipogenesis","volume":"233","author":"Fairfield","year":"2018","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.bone.2021.115913_bb0255","doi-asserted-by":"crossref","first-page":"7808","DOI":"10.1038\/ncomms8808","article-title":"Region-specific variation in the properties of skeletal adipocytes reveals regulated and constitutive marrow adipose tissues","volume":"6","author":"Scheller","year":"2015","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.bone.2021.115913_bb0260","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1080\/21623945.2017.1367881","article-title":"Bone marrow adipocytes","volume":"6","author":"Horowitz","year":"2017","journal-title":"Adipocyte"},{"issue":"10","key":"10.1016\/j.bone.2021.115913_bb0265","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.2337\/db17-0116","article-title":"Bone regulates Browning and Energy metabolism through mature osteoblast\/osteocyte PPAR\u03b3 expression","volume":"66","author":"Brun","year":"2017","journal-title":"Diabetes"},{"issue":"8","key":"10.1016\/j.bone.2021.115913_bb0270","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1111\/j.1464-5491.2010.03048.x","article-title":"Thiazolidinediones induce osteocyte apoptosis and increase sclerostin expression","volume":"27","author":"Mabilleau","year":"2010","journal-title":"Diabet. Med."}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328221000752?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328221000752?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T17:54:36Z","timestamp":1757613276000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328221000752"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":54,"alternative-id":["S8756328221000752"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2021.115913","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.09.13.295378","asserted-by":"object"}]},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PPARG in osteocytes controls sclerostin expression, bone mass, marrow adiposity and mediates TZD-induced bone loss","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2021.115913","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"115913"}}